Co-Infections Lyme disease & Chronic Fatigue Patients
Journal of Chronic Fatigue Syndrome 2008; 14(4): 5-17.
Chronic Fatigue Syndrome Patients
Subsequently Diagnosed with Lyme Disease Borrelia burgdorferi:
Evidence for Mycoplasma species Co-Infections
ABSTRACT
Objective: We examined the blood of 48
North American Chronic Fatigue Syndrome (CFS) patients
subsequently diagnosed with Lyme Disease Borrelia
burgdorferi and compared these to 50 North American CFS
patients without evidence of Borrelia burgdorferi infections
for presence of Mycoplasma spp. co-infections using forensic
polymerase chain reaction.
Results: We found that 68.75% of CFS/Lyme
patients show evidence of mycoplasma co-infections (Odds
Ratio=41.8, Confidence Limits=11.26-155.16, p <0.001)
compared to controls, whereas 50% of CFS patients without a
diagnosis of Lyme Disease Borrelia burgdorferi show
mycoplasma co-infections (OR=19.0,
CL=5.25-68.78, p<0.001 compared to controls). Since CFS
patients without a diagnosis of Lyme Disease have a high
prevalence of one of four Mycoplasma species and a majority
show evidence of multiple infections, we examined CFS/Lyme
patients’ blood for various Mycoplasma species. We found
that CFS patients with Lyme Disease Borrelia burgdorferi
mostly had single species mycoplasma infections (OR=31.67,
CL=8.63-116.16, p<0.001) with a preponderance of M.
fermentans infections (50% of patients, OR=59.0,
CL=7.55-460, p<0.001), whereas the most commonly found
Mycoplasma spp. in CFS patients without Lyme Disease was M.
penumoniae (34% of patients. OR=14.94. CL=3.25-68.73,
p<0.001).
Conclusions: The results indicate that a
subset of CFS patients show evidence of infection with
Borrelia burgdorferi, and a large fraction of these patients
were also infected with Mycoplasma fermentans and to a
lesser degree with other Mycoplasma species.
Mycoplasma Co-Infections
The signs and symptoms of Mycoplasma infection are highly
variable and thus it is not uncommon for a diagnosis to be
entirely missed. A partial list of symptoms includes chronic
fatigue, joint pain, intermittent fevers, headaches,
coughing, nausea, gastrointestinal problems, diarrhea,
visual disturbances, memory loss, sleep disturbances, skin
rashes, joint stiffness, depression, irritability,
congestion, night sweats, loss of concentration, muscle
spasms, nervousness, anxiety, chest pain, breathing
irregularities, balance problems, light sensitivity, hair
loss, problems with urination, congestive heart failure,
blood pressure abnormalities, lymph node pain, chemical
sensitivities, persistent coughing, eye pain, floaters in
the eyes, and many others.
Mycoplasma are pleomorphic bacteria which lack a cell wall
and, as a result, many antibiotics are not effective against
this type of bacteria. There are over 100 known species of
Mycoplasma, but only a half dozen or so are known to be
pathogenic in humans. The pathogenic species are
intracellular and must enter cells to survive. Once they are
inside the cells, they are not recognized by the immune
system and it is difficult to mount an effective response.
They stimulate reactive-oxygen species(ROS) which damage
cell membranes.
|